# Use of postmenopausal hormone therapy and risk of Alzheimer’s disease in Finland: nationwide case-control study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/use-of-postmenopausal-hormone-therapy-and-risk-of-alzheimer-s-disease-in-finland/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Hanna Savolainen‐Peltonen,Päivi Rahkola‐Soisalo,Fabian Hoti,Pia Vattulainen,Mika Gissler,Olavi Ylikorkala,Tomi S. Mikkola |
| Citations | 174 |
| DOI | 10.1136/bmj.l665 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://www.bmj.com/content/bmj/364/bmj.l665.full.pdf |
| OpenAlex ID | https://openalex.org/W2918710227 |
| PMID | 30842086 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Olavi Ylikorkala](https://scholariq.org/researchers/olavi-ylikorkala/)

## Paper journal

- [BMJ](https://scholariq.org/journals/bmj-2/)

## Paper primary topic

- [Menopause: Health Impacts and Treatments](https://scholariq.org/topics/menopause-health-impacts-and-treatments/)

## Paper topics

- [Menopause: Health Impacts and Treatments](https://scholariq.org/topics/menopause-health-impacts-and-treatments/)
- [Dementia and Cognitive Impairment Research](https://scholariq.org/topics/dementia-and-cognitive-impairment-research/)
- [Cancer-related cognitive impairment studies](https://scholariq.org/topics/cancer-related-cognitive-impairment-studies/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.